Medium human tissue biospecimen

Mt Group29 Jan, 2025Business

We respond to inquiries quickly and communicate transparently – if a study isn’t feasible, we tell you that up front. And if study enrollment isn’t going well for whatever reason, we will share that and what we’re doing to fix the situation. That said, we have many multi-specialty sites, which have allowed us to work in diverse disease areas over the years, developing particularly strong capabilities in COVID-19, NASH, inflammatory bowel disease, autoimmune diseases, cardiology, as well as with healthy subjects. Our sites see diverse therapeutic regimens, which allows them to collect many patients either pre- or post- therapy and in some cases, both pre- and post- therapy.